🚨 Call for Papers – Advances in Gastrointestinal Cancers 🔬
We are now accepting submissions for our Special Issue in Frontiers in Cell and Developmental Biology! https://t.co/EBxkrEKtQg
✅ Manuscript Deadline: 3 October 2025 @AIRC_it#CallForPapers#CancerResearch#Oncology
🚨 Are you investigating GI cancers? Don’t miss the opportunity to share your work in our new Research Topic led by Drs. @DonatellaCave, @Forcin3Stefania, @dilettaov, Ottaiano, and Lee!
Make an impact in #cancer#research!
Submit here👉https://t.co/HNKWp1CiKg
#biology
New year new ISCaM Meeting!!
This year's meeting will be held in beautiful BRU (again) and will host a terrific lineup (AGAIN).
As usual, it will fetch plenty of opportunities for networking and fun!
I would like to express my heartfelt gratitude to the National Society of Sciences, Letters, and Arts for awarding me the 'Lisa De Conciliis' Prize 2024. This recognition honors my research on the use of 3D cellular models in cellular pathology. @EnzaLonardo1@CnrIgb@AIRC_it
Which are the highest cited original research publications in #PancreaticCancer over the past five years (from 2020 to 2024 end)?
All metrics obtained from Google Scholar (caveat: GS tends to OVERESTIMATE citations but the trends are consistent overall).
🧵 Below:
🌟 Grateful for the incredible women who I am lucky to work with! Together we will achieve amazing things. Thank you for your support and hard work! 💪 grazie #WomenInScience#ResearchTeam
📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in @CellCellPress by @AmandaARolf , @HansClevers and collaborators. See the article here: https://t.co/xcuc8drybh
.@Novocure ’s Tumor Treating Fields improves overall survival in locally advanced #PancreaticCancer
THE ONLY INTERVENTION TO IMPROVE SURVIVAL WHEN ADDED TO CHEMOTHERAPY.
EVER.
https://t.co/eFScIUvFqf
🌍💜 On this World Pancreatic Cancer Day, our research team stands united in the fight against this devastating disease. #WPCD2024#PancreaticCancer @ItalianPCC@DonatellaCave@mariannaciotola @annalisadidomenico
🚀 Our latest publication explores a novel hybrid nanosystem for #CRC that uses gold nanoparticles and anti-L1CAM antibodies to deliver the TGF-β inhibitor galunisertib directly to tumor-initiating cells. @AIRC_it@CnrIgb@CNRsocial_@DonatellaCave
https://t.co/cjgXHqeAoE